Skip to main content
SpringerLink
Log in

Treatment approaches for acute mania

  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

Abstract

Drug treatment of mania is conceptually divided into mood stabilizers and tranquilizers. Indications for each are defined and a graphical decision tree for treatment of acute mania is presented. The anticonvulsants carbamazepine and valproic acid have an efficacy comparable to that of lithium and work in many lithium-refractory patients. They have not, however, been sufficiently studied in maintenance treatment. Guidelines are presented for the selection of a mood stabilizing agent as well as for combining two mood stabilizers. Lithium-refractoriness, a key concept in determining drug choice, is poorly defined in the literature and requires refinement. Among tranquilizers, neuroleptics are used most frequently, but their use should be minimized. Neuroleptic dosing of manic patients is probably too high and exposes patients to an unnecessary risk of side effects including tardive dyskinesia. In patients with no history of substance abuse, benzodiazepines can be used instead of neuroleptics or in augmentation of neuroleptics which can then be used at lower doses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chou JC: Recent advances in treatment of acute mania. Journal of Clinical Psychopharmacology 11:3–21, 1991.

    Google Scholar 

  2. Chou JC: Drug treatment of mania. Drugs of Today 28(2):119–130, 1992.

    Google Scholar 

  3. Milstein V, Small JG, Klapper MH, et al: Unilateral versus bilateral ECT in the treatment of mania. Convulsive Therapy 3:1–9, 1987.

    Google Scholar 

  4. Small JG, Klapper MH, Kellams JJ, et al: Electroconvulsive treatment compared with lithium in the management of manic states. Archives of General Psychiatry 45:727–732, 1988.

    Google Scholar 

  5. Kane JM, Woerner M, Weinhold P: Incidence and severity of tardive dyskinesia in affective illness, in eds. Gardos G; Casey D, Tardive Dyskinesia and Affective Disorders. Washington, D.C.: American Psychiatric Press, Inc. 21–28, 1984.

    Google Scholar 

  6. Lenox RH, Newhouse PA, Creelman WL, et al: Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study. Journal of Clinical Psychiatry 53:47–52, 1992.

    Google Scholar 

  7. Chou JC, Kosson H, Volavka J: Lorazepam augmentation of low dose haloperidol in acute mania. New Research Abstracts American Psychiatric Association Annual Meeting New Research #70:73, 1990. (Abstract)

  8. Arana GW, Ornsteen ML, Kanter F, et al: The use of benzodiazepines for psychotic disorders: a literature review and preliminary clinical findings. Psychopharmacology Bulletin 22:77–87, 1986.

    Google Scholar 

  9. Post RM, Uhde TW, Roy-Byrne PP, et al: Correlates of antimanic response to carbamazepine. Psychiatry Research 21:71–83, 1987.

    Google Scholar 

  10. Dunner DL, Fleiss JL, Fieve RR: Lithium carbonate prophylaxis failure. British Journal of Psychiatry 129:40, 1976.

    Google Scholar 

  11. Dunner DL, Fieve RR: Clinical factors in lithium carbonate prophylaxis failure. Archives of General Psychiatry 30:229–233, 1974.

    Google Scholar 

  12. Post RM, Leverich GS, Altshuler L, et al: Lithium-discontinuation-induced refractoriness: Preliminary observations. American Journal of Psychiatry 149:1727–1729, 1992.

    Google Scholar 

  13. Okuma T, Inanaga K, Otsuki S, et al: Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study. Psychopharmacology 66:211–217, 1979.

    Google Scholar 

  14. Lerer B, Moore N, Meyendorff E, et al: Carbamazepine versus lithium in mania: A double-blind study. Journal of Clinical Psychiatry 48:3(Mar):89–93, 1987.

    Google Scholar 

  15. Emrich HM, Dose M, Zerssen DV: The use of sodium valproate, carbamazepine, and oxcarbazepine in patients with affective disorders. Journal of Affective Disorders 8:243–250, 1985.

    Google Scholar 

  16. Lusznat RM, Murphy DP, Nunn MH: Carbamazepine vs. lithium in the treatment and prophylaxis of mania. British Journal of Psychiatry 153:198–204, 1988.

    Google Scholar 

  17. Klein E, Bental E, Lerer B, et al: Carbamazepine and haloperidol versus placebo and haloperidol in excited psychoses. Archives of General Psychiatry 41:165–170, 1984.

    Google Scholar 

  18. Goncalves N, Stoll KD: Carbamazepin bei manischen syndromen. Eine kontrollierte doppelblind-studie. Nervenarzt 56:43–47, 1985.

    Google Scholar 

  19. Okuma T, Yamashita I, Takahashi R, et al: Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. Pharmacopsychiatry 23:143–150, 1990.

    Google Scholar 

  20. Small JG, Klapper MH, Milstein V, et al: Carbamazepine compared with lithium in the treatment of mania. Archives of General Psychiatry 48:915–921, 1991.

    Google Scholar 

  21. Stromgren LS, Boller S: Carbamazepine in treatment and prophylaxis of manic-depressive disorder. Psychiatr Dev 4:349–367, 1985.

    Google Scholar 

  22. Okuma T, Yamishita I, Takahashi R, et al: Double blind controlled studies on the therapeutic efficacy of carbamazepine in affective and schizophrenic patients. Psychopharmacology 102, 1988.

  23. Brennan MJW, Sandyk R, Borsook D: Use of sodium valproate in the management of affective disorders: Basic and clinical aspects, in eds. Emrich HM; Okuma T; Muller AA, Anticonvulsants in Affective Disorders. Amsterdam: Excerpta Medica 56–65, 1984.

    Google Scholar 

  24. Freeman TW, Clothier JL, Pazzaglia P, et al: A double-blind comparison of valproate and lithium in the treatment of acute mania. American Journal of Psychiatry 149:108–111, 1992.

    Google Scholar 

  25. Pope HG, McElroy SL, Keck PE, et al: Valproate in the treatment of acute mania. Archives of General Psychiatry 48:62–68, 1991.

    Google Scholar 

  26. Prien RF, Potter WZ: NIMH Workshop report on treatment of bipolar disorder. Psychopharmacology Bulletin 26:409–427, 1990.

    Google Scholar 

  27. Cookson J, Silverstone T, Wells B: Double-blind comparative clinical trial of pimozide and chlorpromazine in mania. Acta Psychiatrica Scandinavica 64:381–397, 1981.

    Google Scholar 

  28. Janicak PG, Bresnahan DB, Sharma R, et al: A comparison of thiothixene with chlorpromazine in the treatment of mania. Journal of Clinical Psychopharmacology 8:33–37, 1988.

    Google Scholar 

  29. Shopsin B, Gershon S, Thompson H: Psychoactive drugs in mania. Archives of General Psychiatry 32:34–42, 1975.

    Google Scholar 

  30. Rifkin A, Karajgi B, Doddi S, et al: Dose and blood levels of haloperidol treatments of mania. Psychopharmacology Bulletin 26:144–146, 1990.

    Google Scholar 

  31. Baldessarini RJ, Cohen BM, Teicher MH: Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Archives of General Psychiatry 45:79–91, 1988.

    Google Scholar 

  32. Bradwejn J, Shriqui C, Koszycki D, et al: Double-blind comparison of the effects of clonazepam and lorazepam in acute mania. Journal of Clinical Psychopharmacology 10:403–408, 1990.

    Google Scholar 

  33. Modell JG, Lenox RH, Weiner S: Inpatient clinical trial of lorazepam for the management of manic agitation. Journal of Clinical Psychopharmacology 5:109–113, 1985.

    Google Scholar 

  34. Lenox RH, Modell JG, Weiner S: Acute treatment of manic agitation with lorazepam. Psychosomatics 27:1(Jan.-suppl):28–31, 1986.

    Google Scholar 

  35. Chouinard G, Young SN, Annable L: Antimanic effects of clonazepam. Biological Psychiatry 18:451–466, 1983.

    Google Scholar 

  36. Salzman C, Green AF, Rodriquez-Villa F, et al: Benzodiazepines combined with neuroleptics for management of severe disruptive behavior. Psychosomatics 27:1(Jan.-suppl):17–21, 1986.

    Google Scholar 

  37. Garza-Trevino ES, Hollister LE, Overall JE, et al: Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation. American Journal of Psychiatry 146:1598–1601, 1989.

    Google Scholar 

  38. Calabrese JR, Delucchi GA: Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. American Journal of Psychiatry 147:431–434, 1990.

    Google Scholar 

  39. McElroy SL, Keck PE, Pope HG, et al: Valproate in the treatment of rapid-cycling bipolar disorder. Journal of Clinical Psychopharmacology 8:275–279, 1988.

    Google Scholar 

  40. Post RM, Uhde TW: Carbamazepine in bipolar illness. Psychopharmacology Bulletin 21:10–17, 1985.

    Google Scholar 

  41. Inoue K, Arima S, Tanaka K, et al: A lithium and carbamazepine combination in the treatment of bipolar disorder—A preliminary report. Folia Psychiatr Neurol Jpn 35:465–475, 1981.

    Google Scholar 

  42. McElroy SL, Keck PE, Pope HG, et al: Valproate in psychiatric disorders. Literature review and clinical guidelines. Journal of Clinical Psychiatry 50(Mar-suppl):23–29, 1989.

    Google Scholar 

  43. Lipinski JF, Pope HG: Possible synergistic action between carbamazepine and lithium carbonate in the treatment of three acutely manic patients. American Journal of Psychiatry 139:948–949, 1982.

    Google Scholar 

  44. Kramlinger KG, Post RM: Adding lithium carbonate to carbamazepine: antimanic efficacy in treatment-resistant mania. Acta Psychiatrica Scandinavica 79:378–385, 1989.

    Google Scholar 

  45. Keck PE, McElroy SL, Vuckovic A, et al: Combined valproate and carbamazepine treatment of bipolar disorder. Journal of Neuropsychiatry & Clinical Neurosciences 4:319–322, 1992.

    Google Scholar 

  46. Ketter TA, Pazzaglia PJ, Post RM: Synergy of carbamazepine and valproic acid in affective illness: case report and review of the literature. Journal of Clinical Psychopharmacology 12:276–281, 1992.

    Google Scholar 

  47. Garza-Trevino ES, Overall JE, Hollister LE: Verapamil versus lithium in acute mania. American Journal of Psychiatry 149:121–122, 1992.

    Google Scholar 

  48. Dubovsky SL, Franks RD, Lifschitz M, et al: Effectiveness of verapamil in the treatment of a manic patient. American Journal of Psychiatry 139:502–504, 1982.

    Google Scholar 

  49. Stancer HC, Persad E: Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Archives of General Psychiatry 39:311–312, 1982.

    Google Scholar 

  50. Bauer MS, Whybrow PC: Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Archives of General Psychiatry 47:435–440, 1990.

    Google Scholar 

  51. Janicak PG, Sharma RP, Easton M, et al: A double-blind, placebo-controlled trial of clonidine in the treatment of acute mania. Psychopharmacology Bulletin 25:243–245, 1989.

    Google Scholar 

  52. Prien RF, Caffey EM, Klett CJ: Relationship between serum lithium level and clinical response in acute mania treated with lithium. British Journal of Psychiatry 120:409–414, 1972.

    Google Scholar 

  53. Spring G, Schweid D, Gray L: A double-blind comparison of lithium and chlorpromazine in the treatment of manic states. American Journal of Psychiatry 126:1306–1310, 1970.

    Google Scholar 

  54. Stokes PE, Stoll PM, Shamoian CH: Efficacy of lithium as acute treatment of manic-depressive illness. Lancet 1319–1325, 1971.

  55. Möller HJ, Kissling W, Riehl T, et al: Double blind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol. Progress in Neuro-Psychopharmacology & Biological Psychiatry 13:127–136, 1989.

    Google Scholar 

  56. Biederman J, Lerner Y, Belmaker RH: Combination of lithium carbonate and haloperidol in schizo-affective disorder. Archives of General Psychiatry 36:327–333, 1979.

    Google Scholar 

  57. Johnstone EC, Crow TJ, Frith CD, et al: The Northwick Park “Functional” psychosis study: Diagnosis and treatment response. Lancet 119–125, 1988.

  58. Garfinkel PE, Stancer HC, Persad E: A comparison of haloperidol, lithium carbonate, and their combination in the treatment of mania. Journal of Affective Disorders 2:279–288, 1980.

    Google Scholar 

  59. Suppes T, McElroy SL, Gilbert J, et al: Clozapine in the treatment of dysphoric mania. Biological Psychiatry 32:270–280, 1992.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nathan S. Kline Institute, 10962, Orangeburg, NY

    James C. -Y. Chou M.D.

Authors
  1. James C. -Y. Chou M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ivan Tuma M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eileen A. Sweeney M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chou, J.C.Y., Tuma, I. & Sweeney, E.A. Treatment approaches for acute mania. Psych Quart 64, 331–344 (1993). https://doi.org/10.1007/BF01064926

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01064926

Keywords

Search

Navigation